Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating Activities:
Net Income	$ 1,511	$ 685
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan and lease losses	547	495
Depreciation	313	247
Amortization of intangibles	4	10
Net amortization of securities premiums	43	1,044
Gain on sales of investment securities	(150)
Earnings on cash surrender value of life insurance	(51)	(58)
SBA loans originated for sale	(468)
Proceeds from sales of SBA loans originated for sale	519
Net gain on sales of SBA loans	(51)
Gain on disposal of property, plant, and equipment		(3)
Loss (gain) on sale/write-down of foreclosed assets	87	(19)
Deferred income tax benefit	(28)	(700)
(Increase) decrease in accrued interest receivable	(200)	47
(Increase) decrease in other assets	(152)	409
Increase in accrued interest payable	93	116
(Decrease) increase in other liabilities	(282)	6,824
Net Cash Provided by Operating Activities	1,735	9,097
Investing Activities:
Net decrease in interest-bearing time deposits with other financial institutions	2,190	6,755
Proceeds from the maturity of investment securities	3,375	15,126
Proceeds from the sale of investment securities	7,199
Purchases of investment securities	(7,462)	(7,995)
(Purchases) redemptions of restricted investment in bank stock	(177)	306
Net increase in loans and leases	(3,982)	(11,401)
Purchases of bank premises and equipment	(499)	(278)
Proceeds from sale of foreclosed assets	64	381
Net Cash Provided by Investing Activities	708	2,894
Financing Activities:
Net increase in demand deposits and savings accounts	1,934	21,658
Net decrease in time deposits	(3,389)	(6,934)
Net increase in short-term borrowings	4,711
Common stock dividend paid	(174)
Employee Stock Purchase Plan	14	15
Warrant repurchase		(58)
Long-term debt repayment	(45)	(733)
Net Cash Provided by Financing Activities	2,964	14,021
Net increase in cash and cash equivalents	5,407	26,012
Cash and cash equivalents, beginning of year	8,623	15,473
Cash and cash equivalents, end of year	14,030	41,485
Supplemental Disclosures of Cash Flow Information:
Interest paid	1,015	1,327
Supplemental Noncash Disclosures:
Loan transfers to foreclosed assets held for sale	264	291
Series B Preferred Stock [Member]
Financing Activities:
Preferred Stock issuance		120
Preferred stock dividend paid	$ (87)	$ (47)